50523-41-6Relevant academic research and scientific papers
NASALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS
-
Paragraph 0010, (2021/10/22)
A nasally administered liquid, including suspension and viscous liquid compositions, containing a therapeutically effective quantity of (Z)-2-(3,5,5-trimethyl-2-cyclohexen-1-ylidene) acetic acid, its salts or analogs, combined with suitable pharmaceutical ingredients, to treat epilepsy and related CNS disorders.
